A rationale to prioritise vaccination of HSCT patients against COVID-19.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Longer-term response to SARS-CoV-2 vaccination after allogeneic blood stem cell transplantation.Journal of cancer research and clinical oncology · 2026
   Article
2. The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients.Clinical & translational immunology · 2026
   Article
3. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.Frontiers in immunology · 2023
   Observational
4. Immunogenicity of SARS-CoV-2 vaccines in patients with cancer.Trends in molecular medicine · 2022
   Review
5. Thrombosis, cancer, and COVID-19.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
   Review
6. COVID-19 vaccination in patients with cancer: Opportunities and challenges.Frontiers in oncology · 2022
   Review
7. Emerging issues related to COVID-19 vaccination in patients with cancer.Oncology and therapy · 2021
   Article
8. The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation.Vaccines · 2021
   Article
9. Administration of COVID-19 vaccines in immunocompromised patients.International immunopharmacology · 2021
   Review

Corrections and comments

• Comment on
  Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as